Palavras-chave
Como Citar
Resumo
As infecções hospitalares, sendo adquiridas durante o período de internação ou mesmo após a alta e decorrentes, majoritariamente, decorrem de um contexto hospitalar multifatorial. Nesse sentido, destacamos como potencializadores a falta de infraestrutura, de estratégias de prevenção sistematizada, além da crescente resistência bacteriana observada nesses ambientes. A pesquisa foi realizada no indexador Pubmed, através do uso dos termos “antimicrobial resistance”, “hospital-acquired infections”, “infection control”, “antibiotic stewardship”, utilizando o operador booleano AND, no ínterim de 2015 a 2025, nos idiomas inglês e português. Os resultados apontam que, com a pandemia da COVID-19, observou-se um aumento excessivo do uso de antibióticos, o que levou ao aumento de infecções por bactérias resistentes e frequentes em UTIs, como Acinetobacter baumanni (resistente a carbapenêmicos) e Klebsiella pneumoniae. Ainda, nota-se a importância não só das medidas desinfecção e higienização, como medidas profiláticas ambientais de controle, mas também programas de gerenciamento de antimicrobianos, para promover um uso racional da classe medicamentosa sem viabilizar ao patógeno resistência no contexto da infecção.
Referências
ABUKHALIL, Abdallah Damin et al. ESKAPE pathogens: antimicrobial resistance patterns, risk factors, and outcomes a retrospective cross-sectional study of hospitalized patients in Palestine. Infection and Drug Resistance, 2024. PMCID: PMC11380491.
CIOFI DEGLI ATTI, M. L. et al. Strategies to control antibiotic resistance: results from a survey in Italian children's hospitals. Ann Ig, 2019. PMID: 30554234.
DOERNBERG, S. B. et al. Priorities and progress in gram-positive bacterial infection research by the Antibacterial Resistance Leadership Group: a narrative review. Clinical Infectious Diseases, 2023. PMCID: PMC10578051
ELTON, Linzy et al. A pandemic within a pandemic? Admission to COVID-19 wards in hospitals is associated with increased prevalence of antimicrobial resistance in two African settings. Annals of Clinical Microbiology and Antimicrobials, 2023. PMCID: PMC10101537.
HARUN, Md Golam Dostogir et al. Rationale and guidance for strengthening infection prevention and control measures and antimicrobial stewardship programs in Bangladesh: a study protocol. BMC Health Services Research, 2022. PMCID: PMC9540083.
IOANNOU, Petros et al. A point prevalence survey of healthcare-associated infections and antimicrobial use in public acute care hospitals in Crete, Greece. Antibiotics, 2022. PMCID: PMC9495163.
LEVY HARA, G. et al. Ten key points for the appropriate use of antibiotics in hospitalised patients: a consensus from the Antimicrobial Stewardship and Resistance Working Groups of the International Society of Chemotherapy. Int J Antimicrob Agents, 2016. PMID: 27502752.
LÓPEZ-VIÑAU, T. et al. Long-term clinical and ecological impact of an antimicrobial stewardship program on the incidence of carbapenem-resistant Klebsiella pneumoniae infections in a high-endemicity hospital. Antibiotics (Basel), 2024. PMCID: PMC11429328.
LUTHANDER, J. et al. Antimicrobial use in a Swedish pediatric hospital: results from eight point-prevalence surveys over a 15-year period (2003-2017). Pediatric Infectious Disease Journal, 2019. PMID: 31220043.
MALANDE, O. O. et al. Invasive carbapenem-resistant Enterobacteriaceae infection at a paediatric hospital: A case series. South African Medical Journal, 2016. PMID: 27601110.
MESCHIARI, M. et al. Combined resistance to ceftolozane-tazobactam and ceftazidime-avibactam in extensively drug-resistant (XDR) and multidrug-resistant (MDR) Pseudomonas aeruginosa: resistance predictors and impact on clinical outcomes besides implications for antimicrobial stewardship programs. Antibiotics (Basel), 2021. PMCID: PMC8532599.
PETRAKIS, V. et al. The impact of the COVID-19 pandemic on antimicrobial resistance and bloodstream infection management. Pathogens, 2023. PMCID: PMC10302285.
PETTIGREW, Melinda M. et al. The human microbiota: new targets for hospital-acquired infections and antibiotic resistance. Annals of Epidemiology, 2016. PMCID: PMC4892961.
RIZK, N. A. et al. The impact of antimicrobial stewardship and infection control interventions on Acinetobacter baumannii resistance rates in the ICU of a tertiary care center in Lebanon. Antibiotics (Basel), 2022. PMCID: PMC9311570.
RUVINSKY, S. et al. Carbapenem-Resistant Enterobacteriaceae Bacteremia in Pediatric Patients in Latin America and the Caribbean: A Systematic Review and Meta-Analysis. Antibiotics (Basel), 2024. PMCID: PMC11672711.
SARTELLI, Massimo et al. Prevention and control of healthcare-associated infections: the first principle of every antimicrobial stewardship program in hospital settings. Antibiotics (Basel), 2024. PMCID: PMC11428707.
SHBAKLO, Nour et al. An observational study of hospital-acquired MDR infections and antibiotic use during the COVID-19 pandemic: a call for antimicrobial stewardship programs. Antibiotics, 2022. PMCID: PMC9138124.
WUNDERINK, R. G. et al. Antibiotic stewardship in the intensive care unit. An official American Thoracic Society workshop report in collaboration with the AACN, CHEST, CDC, and SCCM. Ann Am Thorac Soc., 2020. PMCID: PMC7193806.
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Gisele Neves da Silva, Emily Vitória Pereira Marques, Isadora Belarmino Henriques, Maria Eduarda Sousa Brasil, Tales Freitas Reis Pires, Laísa Carla dos Santos Victor, Beatriz Aguiar Pedroso, Isabela Medeiros Barreto Campello, Sofia Cintra Bezerra, Alvino Luiz Pereira Neto, Maria Gabrielle de Oliveira Costa Campelo, Ruth Maria Mendonça Anacleto